Mechanisms of viral pathogenesis in rheumatic disease

Annals of the Rheumatic Diseases

Volumn 58, Issue 8, 1999, Pages 454-461

  Perl, Andras ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; VIRUS PROTEIN;

ADENOVIRUS; ALPHA VIRUS; ANTIGEN PRESENTATION; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; COXSACKIE VIRUS; CROSS REACTION; CYTOKINE PRODUCTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; RUBELLA VIRUS; VIRUS PATHOGENESIS;

EID: 0032785243     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.8.454     Document Type: Article

References (113)

1. 1 Arnett FC, Reveille JD. Genetics of systemic lupus crythematosus. Rheum Dis Clin North Am 1992;18:865-92.
2. 2 Rothschild BM, Woods RJ, Rothschild C, Sebes JI. Geographic distribution of rheumatoid arthritis in ancient North America: Implications for pathogenesis. Semin Arthritis Rheum 1992;22:181-7.
3. 3 Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998;24:375-401.
4. 4 Phillips PE. Viral arthritis. Curr Opin Rheumatol 1997;9:337-44.
5. 5 Tingle AJ, Mitchell LA, Grace M, Middleton P, Mathias R, MacWilliam L. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997;349:1277-81.
6. 6 Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team [see comments]. JAMA 1997;278:551-6.
7. 7 Frenkel LM, Nielsen K, Garakian A, Jin R, Wolinsky JS, Cherry JD. A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin Infect 1996; 22:287-94.
8. 8 Flexman JP, Smith DW, Mackenzie JS, Fraser JR, Bass SP, Hueston L, et al. A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust 1998;169:159-63.
9. 9 Fraser JR, Becker GJ. Mononuclear cell types in chronic synovial effusions of Ross River virus disease. Aust N Z J Med 1984;14:505-6.
10. 10 Fraser JR, Ratnamohan VM, Dowling JP, Becker GJ, Varigos GA. The exanthem of Ross River virus infection: histology location of virus antigen and nature of inflammatory infiltrate. J Clin Pathol 1983;36:1256-63.
11. 11 Fraser JR. Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis 1986;12:369-88.
12. 12 Panush RS. Adenovirus arthritis. Arthritis Rheum 1974;17:534-6.
13. 13 Rahal JJ, Millian SJ, Noriega ER. Coxsackie and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA 1976;235:2496-501.
14. 14 Fraser KJ, Clarris BJ, Muirden KD, Fraser JR, Jack I. A persistent adenovirus type 1 infection in synovial tissue from an immunodeficient patient with chronic, rheumatoid-like polyarthritis. Arthritis Rheum 1985;28:455-8.
15. 15 Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:1620.
16. 16 Ray CG, Gall EP, Minnich LL, Roediger J, De Benedetti C, Corrigan JJ. Acute polyarthritis associated with active Epstein-Barr virus infection. JAMA 1982;248:2990-3.
17. 17 Le Goff P, Chicault P, Saraux A, Baron D, Valls-Bellec I, Leroy JP. Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus. Rev Rheum Engl Ed 1998;65:283-6.
18. 18 Natkunam Y, Elenitoba-Johnson KS, Kingma DW, Kamel OW. Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. Arthritis Rheum 1997;40: 1152-6.
19. 19 Stebbings S, Highton J, Croxson MC, Powell K, McKay J, Rietveld J. Chickenpox monoarthritis: demonstration of varicella-zoster virus in joint fluid by polymerase chain reaction. Br J Rheumatol 1998;37:311-13.
20. 20 Naucler CS, Larsson S, Moller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996;152:175-92.
21. 21 Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998;7:275-9.
22. 22 Akriviadis EA, Xanthakis I, Navrozidou C, Papadopoulos A. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J Clin Gastroenterol 1997;25:612-18.
23. 23 Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621-4.
24. 24 Gorevic PD, Kassah HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
25. 25 Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN. Clonal B cell expansions in patients with essential mixed cryoglobulinaemia. Clin Exp Immunol 1989;76:54-60.
26. 26 Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
27. 27 Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol 1998; 39:824-6.
28. 28 Nishioka K. HTLV-I arthropathy and Sjogren syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13 (suppl 1):S57-62.
29. 29 Guerin B, Arfi S, Numeric P, Jean-Baptiste G, Le Parc JM, Smadja D. Polyarthritis in HTLV-1-infected patients. A review of 17 cases. Rev Rhum Engl Ed 1995;62:21-8.
30. 30 Beilke MA, Traina-Dorge V, England JD, Blanchard JL. Polymyositis, arthritis, and uveitis in a macaque experimentally infected with human T lymphotropic virus type 1. Arthritis Rheum 1996;39:610-15.
31. 31 Weitzul S, Duvic M. HIV-related psoriasis and Reiter's syndrome. Seminars in Cutaneous Medicine and Surgery 1997;16:213-18.
32. 32 Espinoza LR, Cuellar ML. Retrovirus-associated rheumatic syndromes. Koopman WJ, ed. Arthritis and allied conditions. Baltimore: Williams and Wilkins, 1998:2361.
33. 33 Sigurdsson B, Palsson P, Grimsson H. Visna, a demyelinating transmissible disease of the sheep. J Neuropathol Exp Neurol 1957;16:389-403.
34. 34 Narayan O, Cork LC. Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Reviews of Infections Diseases 1985;7:89-98.
35. 35 Cork LC, Hadlow WJ, Crawford TB, Gorham JR, Piper RC. Infectious leukoencephalomyclitis of young goats. J Infect Dis 1974;129:134-41.
36. 36 Cheevers WP, Beyer JC, Knowles DP. Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 1997;71:6259-63.
37. 37 Lechner F, Vogt HR, Seow HF, Bertoni G, Cheevers WT, von Rodungen U, et al. Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997;151:1053-65.
38. 38 Rich SA Human lupus inclusions and interferon. Science 1981 213:772-5.
39. 39 Stransky G, Vernon J, Aicher WK, Moreland LW, Gay RE. Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br J Rheumatol 1993;32:1044-8.
40. 40 Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV infection. Science 1992;257:217-19.
41. 41 Emlen W, Niebur JA, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
42. 42 Calabrese L. The rheumatic manifestations of infection with the HIV. Semin Arthritis Rheum 1989;18:225-39.
43. 43 Inman RD, Perl A, Phillips PE. Infectious agents in chronic rheumatic diseases. Koopman WJ, ed. Arthritis and allied conditions. A textbook of rheumatology. Philadelphia: Lea and Febiger, 1997:585.
44. 44 Yoshiki T, Mellors RC, Strand M, August JT. The viral envelope glycoprotein of murine leukemia virus and the pathoegenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974;140:1011-25.
45. 45 Krieg AM, Gourley MF, Perl A. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992;6:2537-44.
46. 46 Banki K, Maceda J, Hurley E, Ablonezy E, Mattson DH, Szegedy L, et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992;89:1939-43.
47. 47 Perl A, Colombo E, Dai H, Agarwal RK, Mark KA, Banki K, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995;38:1660-71.
48. 48 Brookes SM, Pandoltino YA, Mitchell TJ, Venables TJW, Shattles WG, Clark DA, et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992;31: 735-12.
49. 49 Bengtsson A, Blomberg J, Nived O, Pipkorn R, Toth L, Sturfelt G. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus crythematosus. Arthritis Rheum 1996;39:1654-63.
50. 50 Li J, Fan WS, Horsfall AC, Anderson AC, Rigby S, Larsson E, et al. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 1996;104:388-93.
51. 51 Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.
52. 52 Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996;17:466-70.
53. gag antigen. Cell 1987;51:211-20.
54. 54 Perl A, Rosenblatt JD, Chen IS, DiVincenzo JP, Bever R, Poiesz BJ, et al. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989;17:6841-54.
55. 55 Sela M. Antigenicity: some molecular aspects. Science 1969;166:1365-74.
56. 56 Perl A, Isaacs CM, Eddy RL, Byers MG, Sait SN, Shows TB. The human T-cell leukemia virus-related endogenous sequence (HRES1) is located on Chromosome 1 at q42. Genomics 1991;11:1172-3.
57. 57 Magistrelli C, Banki K, Ferrante P, Perl A. Mapping and cloning of polymorphic genorypes of the HRES-1 LTR. Arthritis Rheum 1994;37: S316.
58. 58 Tsao BP, Cantor RM, Kalunian KC, Chen C, Badsha H, Singh R, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997;99:725 -31.
59. 59 Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990;85:1866-71.
60. 60 Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies form patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol 1993;23:1146-52.
61. 61 Vaughan JH, Nguyen M, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr Virus-induced Autoimmune Responses II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995;95:1316-27.
62. 62 Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM. Systemic lupus erythematosus. Ann Intern Med 1991;115:548-59.
63. 63 James JJ, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patientts suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
64. 64 Misaki Y, Yamamoto K, Yanagi K, Miura H, Ichijo H, Kato T, et al. B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein. Eur J Immunol 1993;23:1064-71.
65. 65 Kohsaka H, Yamamoto K, Fujii H, Miura H, Miyasaka N, Nishioka K, et al. Fine epitope mapping of the human SS-B La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. J Clin Invest 1990;85:1566-74.
66. 66 Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985;230:453-5.
67. 67 Perl A, Banki K. Human endogenous retroviral elements and autoimmunity: data and concepts. Trends Microbiol 1993;1:153-6.
68. 68 Zhu ZB, Hsieh S, Bentley DR, Campbell D, Volanakis JE. A variable number of tandem repeat locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 1992;175:1783-87.
69. 69 Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
70. 70 Tsokos GC. Overview of cellular immune function in systemic lupus erythematosus. Lahita RG, ed. Systemic lupus erythematosus. New York: Churchill Livingstone, 1992:15.
71. 71 Dayal AK, Kammer GM: The T cell enigma in lupus. Arthritis Rheum 1996;39:23-33.
72. 72 Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
73. 73 Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytcs. J Exp Med 1994;179:1317-30.
74. 74 Haraguchi S, Good RA, Day NK. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 1995;16:595-603.
75. 75 Ruegg CL, Strand M. A synthetic peptide with sequence identity to the transmembrane protein gp41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cell Immunol 1991;137:1-13.
76. 76 Gao J, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J Biol Chem 1994;269:28539 42.
77. 77 Paxton WA, Dragic T, Koup RA, Moore JP. The β-chemokines, HIV type 1 second receptors, and exposed uninfected persons. AIDS Res Hum Retroviruses 1996;12:1203-7.
78. 78 Hill A, Jugovie P, York I, Russ G, Bennink J, Yewdell J, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-15.
79. 79 Burgert H, Kvist S. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J 1987;6:2019-26.
80. 80 Prottitt JL, Sharma E, Blair GE. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Nucleic Acids Res 1994;22:4779-88.
81. 81 Li Z, Turk SM, Hutt-Fletcher LM. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 1995;69:3987-94.
82. 82 Mossman K, Upton C, McFadden G. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon -gamma in a species-specific manner.J Biol Chem 1995;270:3031-8.
83. 83 Upton C, Macen JL, Schreiber M, McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991;184:370-82.
84. 84 Ehret A, Westendorp MO, Herr I, Dcbatin K, Heeney JL, Frank R, et al. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 rat-enhanced oxidative stress and apoptosis. J Virol 1996;70:6502-7.
85. 85 Banki K, Hutter E, Gonchoroff NJ, Perl A. Molecular ordering in HIV-induced apoptosis: Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J Biol Chem 1998;273:11944-53.
86. 86 Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 1995;375:497-500.
87. 87 Strack PR, Frey MW, Rizzo CJ, Cordova B, George HJ, Meade R, et al. Apoptosis mediated by HIV protease is preceeded by cleavage of bcl-2. Proc NatI Acad Sci USA 1996;93:9571-6.
88. 88 Morey AL, Ferguson DJ, Fleming KA. Ultrastructural features of fetal crythroid precursors infected with parvovirus B19 in vitro: evidence for cell death by apoptosis. J Pathol 1993;169:213-20.
89. 89 Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 1994;68:3667-73.
90. 90 Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998;28: 936-48.
91. 91 Gendelman R, Orzech Y, Mashiah P, Birenbaum M, Gazit A, Yaniv A. Productive replication of caprine arthritis-encephalitis virus is associated with induction of apoptosis. J Gen Virol 1997;78:801-5.
92. 92 Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012-16.
93. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 1996;70:2324-31.
94. 94 Planelles V, Jowett JBM, Li Q, Xie Y, Hahn B, Chen ISY. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol 1996;70:2516-24.
95. 95 Rao L, Debbas M, Sabbatini P, Hockenberry D, Korsmeyer S, White E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and bcl-2 proteins. Proc Natl Acad Sci USA 1992;89:7742-6.
96. 96 Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993;90:8479-83.
97. 97 Chou J, Roizman B. The gamma, 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc Natl Acad Sci USA 1992;89:3266-70.
98. 98 Yamada T, Yamaoka S, Goto T, Nakai M, Tsujimoto Y, Hatanaka M. The human T-cell leukemia virus type 1 tax protein induces apoptosis which is blocked by the bcl-2 protein. J Virol 1994;68:3374-9.
99. 99 Masutani H, Hirota K, Sasada T, Ueda-Taniguchi Y, Taniguchi Y, Sono H, et al. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I tax. Immunol Lett 1996;54:67-71.
100. 100 Kishi S, Saijyo S, Arai M, Karasawa S, Ueda S, Kannagi M, et al. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type 1 (HTLV-1) transgenic mice with autoimmune arthropathy. J Exp Med 1997;186:57-64.
101. 101 Banki K, Hutter E, Colombo E, Gonchoroff NJ, Perl A. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J Biol Chem 1996;271:32994-3001.
102. 102 Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-28.
103. 103 Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjogren's syndrome in HTLV-I tax transgenic mice. Nature 1989;341:72-4.
104. 104 Thome M, Schneider P, Hofman K, Fickenscher H, Meinl E, Neipel F, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997;386:517-21.
105. 105 Bertin J. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFRI-induced apoptosis. Proc Natl Acad Sci USA 1997;94:1172-6.
106. 106 Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin North Am 1990;16:617-39.
107. 107 Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-51.
108. 108 Joklik WK. Interferons. Fields BN, ed. Virology. New York: Raven Press, 1985:281.
109. 109 Cross CL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ. Regulation of the human interleukin-2 receptor alpha promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 1987;49:47-56.
110. 110 Collette Y, Chang H, Cerdan C, Chambost H, Algarte M, Mawas C, et al. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 ncf gene-induced expression. J Immunol 1996;156:360-70.
111. 111 Rubartelli A, Poggi A, Sitia R, Zocchi MR. HIV-1 tat: a polypeptide for all seasons. Immunol Today 1998;19:543-5.
112. 112 Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281: 1309-12.
113. 113 Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-6.